Evidence map›Paper›PMID 31367063›Full record

ArticleAIChE journal. American Institute of Chemical Engineers2019

Metastatic cancer cell attachment to endothelium is promoted by endothelial glycocalyx sialic acid degradation.

Solomon A Mensah, Ian C Harding, Michelle Zhang, Michael P Jaeggli, Vladimir P Torchilin, Mark J Niedre, Eno E Ebong

Open access · hybridAbstract read
In one paragraph

Article in AIChE journal. American Institute of Chemical Engineers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. The Progress of Platelets in Breast Cancer.Cancer management and research · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Flow-regulated endothelial glycocalyx determines metastatic cancer cell activity.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  14. Aberrant sialylation in ovarian cancers.Journal of the Chinese Medical Association : JCMA · 2020
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Solomon A MensahBioengineering Department, Northeastern University, Boston, Massachusetts.
Ian C HardingBioengineering Department, Northeastern University, Boston, Massachusetts.
Michelle ZhangChemical Engineering Department, Northeastern University, Boston, Massachusetts.
Michael P JaeggliBioengineering Department, Northeastern University, Boston, Massachusetts.
Vladimir P TorchilinPharmaceutical Sciences Department, Northeastern University, Boston, Massachusetts.
Mark J NiedreBioengineering Department, Northeastern University, Boston, Massachusetts.
Eno E EbongBioengineering Department, Northeastern University, Boston, Massachusetts.ORCID 0000-0001-9483-1443
Northeastern University · US

Funding

Atheroprotective vs. Atherogenic Glycocalyx Mechanotransduction MechanismsK01HL125499 · NHLBI · NORTHEASTERN UNIVERSITY · PI EBONG, ENO ESSIEN · 2015 to 2019
$770k
NHLBI NIH HHS K01 HL125499
6 · The paper itself

Abstract

While it is known that cancer cell interactions with vascular endothelial cells (ECs) drive metastatic cancer cell extravasation from blood vessels into secondary tumor sites, the mechanisms of action are still poorly understood. Here, we tested the hypothesis that neuraminidase-induced degradation of EC surface glycocalyx (GCX), particularly the sialic acid (SA) residue components of the GCX, will substantially increase metastatic cancer cell attachment to ECs. To our knowledge, our study is the first to isolate the role of GCX SA residues in cancer cell attachment to the endothelium, which were found to be differentially affected by the presence of neuraminidase and to indeed regulate metastatic cancer cell homing to ECs. We hope that this work will eventually translate to identification of EC GCX-based cancer markers that can be therapeutically targeted to hinder the progression of metastasis.

Indexed as

endothelial glycocalyxmetastatic cancer cellssecondary tumorsialic acid

Identifiers

PMID31367063
PMCPMC6668365
OpenAlexW2943908556

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.